ReviewHypertension research : official journal of the Japanese Society of Hypertension2026
Hypertension in children and adolescents: emerging global evidence and clinical implications.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment on "Lean body mass index and hypertension risk in men: a nationwide epidemiological cohort study".Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Dietary intakes of cysteine, glutamate, proline, and tryptophan are associated with hypertension risk in Chinese children and adolescents: a national cross-sectional study integrating machine learning.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension in children and adolescents is a growing public health concern; it poses immediate risks to health and frequently persists into adulthood, where it accelerates target organ damage and adverse cardiovascular and renal outcomes. This review summarizes recent studies published between 2024 and 2025 addressing hypertension in children and adolescents. Recent findings highlight obesity and asthma as major risk factors and point to systemic inflammation as a potential biomarker. Longitudinal cohort studies show that hypertension during childhood and adolescence strongly predicts future cardiovascular events and kidney disease, reinforcing the need for early detection and intervention. Together, these studies establish hypertension in youth as a distinct clinical entity that requires timely recognition and management. School- and community-based screening, education, and lifestyle interventions are promising approaches to reduce both its prevalence and long-term complications. Future research should clarify mechanistic links with inflammation, identify sensitive biomarkers for early detection, and evaluate tailored preventive strategies. Coordinated, multidisciplinary efforts will be essential to mitigate the lifelong burden of hypertension originating in childhood and adolescence.
Indexed as
Identifiers
41238808What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.